-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NTeDsxtfjBBrccaLbc87xmXC6QWGua8+x/PVauShLyCvNkdxV65MIpJ7T/Qbpfsy axbOb/+JhmbQc5yCIgHrig== 0001238940-05-000004.txt : 20050214 0001238940-05-000004.hdr.sgml : 20050214 20050214192321 ACCESSION NUMBER: 0001238940-05-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050210 FILED AS OF DATE: 20050214 DATE AS OF CHANGE: 20050214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WATLINGTON THOMAS M CENTRAL INDEX KEY: 0001238940 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21873 FILM NUMBER: 05613923 BUSINESS ADDRESS: STREET 1: C/O BIOSITE INC STREET 2: 11030 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584554808 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSITE INC CENTRAL INDEX KEY: 0000834306 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 330288606 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6194554808 MAIL ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: BIOSITE DIAGNOSTICS INC DATE OF NAME CHANGE: 19960710 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2005-02-10 0 0000834306 BIOSITE INC BSTE 0001238940 WATLINGTON THOMAS M BIOSITE INCORPORATED 11030 ROSELLE STREET SAN DIEGO CA 92121 0 1 0 0 EVP & COO Common Stock 2005-02-10 4 M 0 1000 13.875 A 1650 D Common Stock 2005-02-10 4 S 0 1000 60.5947 D 650 D Common Stock 2005-02-10 4 M 0 5000 13.875 A 5650 D Common Stock 2005-02-10 4 S 0 5000 60.7765 D 650 D Incentive Stock Option (right to buy) 10 2005-02-10 4 M 0 4912 59.69 D 1999-06-09 2009-06-09 Common Stock 4912 3861 D Incentive Stock Option (right to buy) 10 2005-02-10 4 M 0 1000 59.8136 D 1999-06-09 2009-06-09 Common Stock 1000 2861 D Incentive Stock Option (right to buy) 10 2005-02-10 4 M 0 1000 59.8963 D 1999-06-09 2009-06-09 Common Stock 1000 1861 D Incentive Stock Option (right to buy) 10 2005-02-10 4 M 0 1000 59.9275 D 1999-06-09 2009-06-09 Common Stock 1000 861 D Incentive Stock Option (right to buy) 10 2005-02-10 4 M 0 861 60.1571 D 1999-06-09 2009-06-09 Common Stock 861 0 D Non-Qualified Stock Option (right to buy) 13.875 2005-02-10 4 M 0 139 60.1571 D 1998-05-21 2008-05-21 Common Stock 139 18000 D Non-Qualified Stock Option (right to buy) 13.875 2005-02-10 4 M 0 1000 60.2028 D 1998-05-21 2008-05-21 Common Stock 1000 17000 D Non-Qualified Stock Option (right to buy) 13.875 2005-02-10 4 M 0 1000 60.2713 D 1998-05-21 2008-05-21 Common Stock 1000 16000 D Non-Qualified Stock Option (right to buy) 13.875 2005-02-10 4 M 0 1000 60.3142 D 1998-05-21 2008-05-21 Common Stock 1000 15000 D Non-Qualified Stock Option (right to buy) 13.875 2005-02-10 4 M 0 4000 60.34 D 1998-05-21 2008-05-21 Common Stock 4000 11000 D Non-Qualified Stock Option (right to buy) 13.875 2005-02-10 4 M 0 1000 60.3492 D 1998-05-21 2008-05-21 Common Stock 1000 10000 D Non-Qualified Stock Option (right to buy) 13.875 2005-02-10 4 M 0 1000 60.3664 D 1998-05-21 2008-05-21 Common Stock 1000 9000 D Non-Qualified Stock Option (right to buy) 13.875 2005-02-10 4 M 0 1000 60.3813 D 1998-05-21 2008-05-21 Common Stock 1000 8000 D Non-Qualified Stock Option (right to buy) 13.875 2005-02-10 4 M 0 1000 60.4079 D 1998-05-21 2008-05-21 Common Stock 1000 7000 D Non-Qualified Stock Option (right to buy) 13.875 2005-02-10 4 M 0 1000 60.4303 D 1998-05-21 2008-05-21 Common Stock 1000 6000 D Non-Qualified Stock Option (right to buy) 13.875 2005-02-10 4 M 0 1000 60.5947 D 1998-05-21 2008-05-21 Common Stock 1000 5000 D Non-Qualified Stock Option (right to buy) 13.875 2005-02-10 4 M 0 5000 60.7765 D 1998-05-21 2008-05-21 Common Stock 5000 0 D Option vests daily over a four-year period commencing on the date of grant, except that no options are exercisable for the first six months after the date of grant. By: Robyn Shutak For: Thomas M. Watlington 2005-02-14 -----END PRIVACY-ENHANCED MESSAGE-----